These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30207211)
1. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Sandomenico A; Ruvo M Curr Med Chem; 2019; 26(11):1994-2050. PubMed ID: 30207211 [TBL] [Abstract][Full Text] [Related]
2. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698 [TBL] [Abstract][Full Text] [Related]
3. Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro. Focà G; Iaccarino E; Focà A; Sanguigno L; Untiveros G; Cuevas-Nunez M; Strizzi L; Leonardi A; Ruvo M; Sandomenico A Biochimie; 2019 Mar; 158():246-256. PubMed ID: 30703478 [TBL] [Abstract][Full Text] [Related]
4. Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells. Arnouk H; Yum G; Shah D Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502188 [TBL] [Abstract][Full Text] [Related]
5. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Strizzi L; Bianco C; Normanno N; Salomon D Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806 [TBL] [Abstract][Full Text] [Related]
6. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding. Focà A; Sanguigno L; Focà G; Strizzi L; Iannitti R; Palumbo R; Hendrix MJ; Leonardi A; Ruvo M; Sandomenico A Int J Mol Sci; 2015 Sep; 16(9):21342-62. PubMed ID: 26370966 [TBL] [Abstract][Full Text] [Related]
7. Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis. Kenney NJ; Adkins HB; Sanicola M J Mammary Gland Biol Neoplasia; 2004 Apr; 9(2):133-44. PubMed ID: 15300009 [TBL] [Abstract][Full Text] [Related]
8. Role of Cripto-1 in stem cell maintenance and malignant progression. Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345 [TBL] [Abstract][Full Text] [Related]
9. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Strizzi L; Postovit LM; Margaryan NV; Seftor EA; Abbott DE; Seftor RE; Salomon DS; Hendrix MJ Breast Dis; 2008; 29():91-103. PubMed ID: 19029628 [TBL] [Abstract][Full Text] [Related]
10. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer. Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493 [TBL] [Abstract][Full Text] [Related]
11. Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer. Francescangeli F; Contavalli P; De Angelis ML; Baiocchi M; Gambara G; Pagliuca A; Fiorenzano A; Prezioso C; Boe A; Todaro M; Stassi G; Castro NP; Watanabe K; Salomon DS; De Maria R; Minchiotti G; Zeuner A Cell Death Differ; 2015 Oct; 22(10):1700-13. PubMed ID: 26343543 [TBL] [Abstract][Full Text] [Related]
12. Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo. Liguori GL; Borges AC; D'Andrea D; Liguoro A; Gonçalves L; Salgueiro AM; Persico MG; Belo JA Dev Biol; 2008 Mar; 315(2):280-9. PubMed ID: 18241853 [TBL] [Abstract][Full Text] [Related]
13. Targeting the embryonic gene Cripto-1 in cancer and beyond. Bianco C; Salomon DS Expert Opin Ther Pat; 2010 Dec; 20(12):1739-49. PubMed ID: 21073352 [TBL] [Abstract][Full Text] [Related]
14. A GPI processing phospholipase A2, PGAP6, modulates Nodal signaling in embryos by shedding CRIPTO. Lee GH; Fujita M; Takaoka K; Murakami Y; Fujihara Y; Kanzawa N; Murakami KI; Kajikawa E; Takada Y; Saito K; Ikawa M; Hamada H; Maeda Y; Kinoshita T J Cell Biol; 2016 Dec; 215(5):705-718. PubMed ID: 27881714 [TBL] [Abstract][Full Text] [Related]
15. An evolving web of signaling networks regulated by Cripto-1. Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969 [TBL] [Abstract][Full Text] [Related]
16. Cripto: a tumor growth factor and more. Adamson ED; Minchiotti G; Salomon DS J Cell Physiol; 2002 Mar; 190(3):267-78. PubMed ID: 11857442 [TBL] [Abstract][Full Text] [Related]
17. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors. Spiller CM; Bowles J; Koopman P Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832 [TBL] [Abstract][Full Text] [Related]
18. Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Harms PW; Chang C Genes Dev; 2003 Nov; 17(21):2624-9. PubMed ID: 14563676 [TBL] [Abstract][Full Text] [Related]
19. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855 [TBL] [Abstract][Full Text] [Related]
20. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth. Ishii H; Zahra MH; Takayanagi A; Seno M Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]